Koji Muroya
Overview
Explore the profile of Koji Muroya including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
101
Citations
1045
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Clinicopathological and genomic analysis of pediatric pheochromocytoma and sympathetic paraganglioma
Kimura N, Muroya K, Yonamine M, Takekoshi K, Sato T, Hirose R, et al.
Endocr J
. 2025 Feb;
PMID: 39894509
Pediatric patients with pheochromocytoma (PCC)/paraganglioma (PGL) (PPGL) are rare, and clinicopathological investigations, especially the relationship between gene analysis and histological features, are insufficient. We comprehensively examined the clinical data, germline/somatic...
2.
Hayashi M, Narumi S, Sato T, Amano N, Suwanai A, Haruna H, et al.
J Clin Endocrinol Metab
. 2024 Nov;
PMID: 39569443
Context: 46,XY differences of sex development (DSD) are heterogeneous in etiology. The detailed phenotypes of 46,XY DSD patients with monogenic disorders have not been fully elucidated. Objectives: To estimate the...
3.
Uehara E, Abe K, Tanase-Nakao K, Muroya K, Hattori A, Matsubara K, et al.
Thyroid
. 2024 May;
34(7):827-836.
PMID: 38757580
is one of the major causative genes of congenital hypothyroidism (CH). Still, the mutation spectrum and clinical outcomes of biallelic variants are not fully understood. This study aimed to elucidate...
4.
Hirano Y, Kuroda Y, Enomoto Y, Naruto T, Muroya K, Kurosawa K
Am J Med Genet A
. 2024 May;
194(9):e63652.
PMID: 38741564
Noonan syndrome is a so-called "RASopathy," that is characterized by short stature, distinctive facial features, congenital heart defects, and developmental delay. Of individuals with a clinical diagnosis of Noonan syndrome,...
5.
Narumi S, Nagasaki K, Kiriya M, Uehara E, Akiba K, Tanase-Nakao K, et al.
Nat Genet
. 2024 May;
56(5):869-876.
PMID: 38714868
Insufficient thyroid hormone production in newborns is referred to as congenital hypothyroidism. Multinodular goiter (MNG), characterized by an enlarged thyroid gland with multiple nodules, is usually seen in adults and...
6.
Ward L, Hogler W, Glorieux F, Portale A, Whyte M, Munns C, et al.
JBMR Plus
. 2024 May;
8(1):ziad001.
PMID: 38690124
In a randomized, open-label phase 3 study of 61 children aged 1-12 years old with X-linked hypophosphatemia (XLH) previously treated with conventional therapy, changing to burosumab every 2 weeks (Q2W)...
7.
Hatano M, Tanase-Nakao K, Uehara E, Iwano R, Muroya K, Narumi S
Clin Pediatr Endocrinol
. 2024 Apr;
33(2):94-100.
PMID: 38572382
Most patients with resistance to thyroid hormone (RTH) test negative in newborn screening (NBS) for congenital hypothyroidism (CH). Here, we present a case of RTH diagnosed through NBS. The patient...
8.
Tanase-Nakao K, Iwahashi-Odano M, Sugisawa C, Abe K, Muroya K, Yamamoto Y, et al.
J Clin Endocrinol Metab
. 2024 Feb;
109(9):2358-2365.
PMID: 38373250
Context: Thyroglobulin (Tg), encoded by TG, is essential for thyroid hormone synthesis. TG defects result in congenital hypothyroidism (CH). Most reported patients were born before the introduction of newborn screening...
9.
Imel E, Glorieux F, Whyte M, Portale A, Munns C, Nilsson O, et al.
J Clin Endocrinol Metab
. 2023 Apr;
108(11):2990-2998.
PMID: 37084401
Context: In an open-label, randomized, controlled, phase 3 trial in 61 children aged 1 to 12 years with X-linked hypophosphatemia (XLH), burosumab improved rickets vs continuing conventional therapy with active...
10.
Kawai M, Muroya K, Murakami N, Ihara H, Takahashi Y, Horikawa R, et al.
Endocr J
. 2023 Feb;
70(5):519-528.
PMID: 36792176
Prader-Willi syndrome (PWS) is a multisystem disorder with increased mortality predominantly due to obesity-associated complications; therefore, the management of obesity has been centric to therapeutic strategies for PWS. Although a...